FDA greenlights Medtronic’s dual-energy ablation—could this be the future of AFib treatment?
Medtronic has achieved a major milestone with the U.S. Food and Drug Administration (FDA) granting approval for its Affera Mapping and Ablation System, including the ... Read More
Boston Scientific to acquire Silk Road Medical for $1.2bn to enhance stroke prevention capabilities
Boston Scientific Corporation (NYSE: BSZ) has announced its definitive agreement to acquire Silk Road Medical, Inc. (Nasdaq: SILK) for $27.50 per share, reflecting an enterprise ... Read More
Boston Scientific to enhance urology portfolio by acquiring Axonics in $3.7bn deal
Boston Scientific Corporation (NYSE: BSX) has entered into a definitive agreement to acquire Axonics, Inc. (Nasdaq: AXNX), a leading medical technology company specializing in urinary ... Read More
Boston Scientific to buy medical technology company Relievant Medsystems for $850m
Boston Scientific Corporation has struck a definitive deal to purchase Relievant Medsystems for an upfront payment of $850 million. Additional undisclosed contingent payments are also ... Read More
Boston Scientific to take majority stake in Acotec Scientific for $523m
Boston Scientific, a US medical device maker, has offered to acquire a stake of up to 65% in Chinese medical technology company Acotec Scientific for ... Read More
Boston Scientific to acquire medical technology company Apollo Endosurgery
Boston Scientific has agreed to acquire Texas-based medical technology company Apollo Endosurgery in an all-cash transaction with an enterprise value of nearly $615 million. As ... Read More
Boston Scientific ACURATE neo2 Aortic Valve System delivers procedural success rate of 98%
Boston Scientific said that the ACURATE neo2 Aortic Valve System delivered a high procedural success rate of 98.4% and low rates of paravalvular leak (PVL) ... Read More
Boston Scientific to acquire Baylis Medical Company for $1.7bn
Boston Scientific has agreed to acquire Baylis Medical Company, a Canadian medical devices manufacturer in the field of cardiology, for $1.75 billion. The deal does ... Read More
Boston Scientific wraps up $1bn acquisition of Lumenis surgical business
Boston Scientific has wrapped up the previously announced $1.07 billion acquisition of the global surgical business of Israeli medical solutions provider Lumenis. The US medical ... Read More
Boston Scientific to acquire Lumenis surgical business for $1bn
Boston Scientific has agreed to acquire the global surgical business of Israel-based energy-based medical solutions provider Lumenis for $1.07 billion in cash. In this connection, ... Read More